Cargando…

Exploiting Mitochondrial Dysfunction for Effective Elimination of Imatinib-Resistant Leukemic Cells

Challenges today concern chronic myeloid leukemia (CML) patients resistant to imatinib. There is growing evidence that imatinib-resistant leukemic cells present abnormal glucose metabolism but the impact on mitochondria has been neglected. Our work aimed to better understand and exploit the metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kluza, Jérome, Jendoubi, Manel, Ballot, Caroline, Dammak, Abir, Jonneaux, Aurélie, Idziorek, Thierry, Joha, Sami, Dauphin, Véronique, Malet-Martino, Myriam, Balayssac, Stéphane, Maboudou, Patrice, Briand, Gilbert, Formstecher, Pierre, Quesnel, Bruno, Marchetti, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138741/ https://www.ncbi.nlm.nih.gov/pubmed/21789194 http://dx.doi.org/10.1371/journal.pone.0021924

Ejemplares similares

Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor
por: Corazao-Rozas, Paola, et al.
Publicado: (2013)

Another Facet to the Anticancer Response to Lamellarin D: Induction of Cellular Senescence through Inhibition of Topoisomerase I and Intracellular Ros Production
por: Ballot, Caroline, et al.
Publicado: (2014)

Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors
por: Khamari, Raeeka, et al.
Publicado: (2018)

GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells
por: Joha, S, et al.
Publicado: (2012)

Exploiting the promiscuity of imatinib
por: Lee, Shun J, et al.
Publicado: (2009)

Correction: Exploiting the promiscuity of imatinib
por: Lee, Shun J, et al.
Publicado: (2010)

Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
por: Trinh, Anne, et al.
Publicado: (2021)

A new hypothesis: imatinib affects leukemic stem cells in the same way it affects all other leukemic cells
por: Tomasetti, C
Publicado: (2011)

Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells
por: Glamoclija, Una, et al.
Publicado: (2022)

Chemometric Analysis of Low-field (1)H NMR Spectra for Unveiling Adulteration of Slimming Dietary Supplements by Pharmaceutical Compounds
por: Wu, Nao, et al.
Publicado: (2020)

Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib
por: Feriotto, Giordana, et al.
Publicado: (2021)

MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells
por: Kaehler, Meike, et al.
Publicado: (2017)

Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
por: Blackman, Ronald K., et al.
Publicado: (2012)

Melanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells
por: Touil, Yasmine, et al.
Publicado: (2016)

Apoptosis-related mitochondrial dysfunction defines human monocyte-derived dendritic cells with impaired immuno-stimulatory capacities
por: Castera, Laurent, et al.
Publicado: (2009)

(1)H NMR Analysis of Cerebrospinal Fluid from Alzheimer’s Disease Patients: An Example of a Possible Misinterpretation Due to Non-Adjustment of pH
por: Cruz, Thomas, et al.
Publicado: (2014)

p65/RelA NF‐κB fragments generated by RIPK3 activity regulate tumorigenicity, cell metabolism, and stemness characteristics
por: Touil, Yasmine, et al.
Publicado: (2021)

Comparative Chemical Profiling and Monacolins Quantification in Red Yeast Rice Dietary Supplements by (1)H-NMR and UHPLC-DAD-MS
por: Hachem, Rabab, et al.
Publicado: (2020)

Imatinib mesylate can help to direct natural immunity toward an anti-leukemic reactivity by acting on the bone marrow microenvironment
por: Poggi, Alessandro, et al.
Publicado: (2012)

Put in a “Ca(2+)ll” to Acute Myeloid Leukemia
por: Lewuillon, Clara, et al.
Publicado: (2022)

Metabolic assessment of a novel chronic myelogenous leukemic cell line and an imatinib resistant subline by (1)H NMR spectroscopy
por: Dewar, Brian J., et al.
Publicado: (2010)

Synergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist
por: Zhang, Manchao, et al.
Publicado: (2013)

NMR-Based Μetabolomics of the Lipid Fraction of Organic and Conventional Bovine Milk
por: Tsiafoulis, Constantinos G., et al.
Publicado: (2019)

Gingival Leukemic Infiltration in Chronic Lymphocytic Leukemia
por: Kacem, Karima, et al.
Publicado: (2019)

Fusarium inhibition by wild populations of the medicinal plant Salvia africana-lutea L. linked to metabolomic profiling
por: Nkomo, Mpumelelo M, et al.
Publicado: (2014)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
por: Touzet, Lucas, et al.
Publicado: (2019)

Clinically Relevant Oxygraphic Assay to Assess Mitochondrial Energy Metabolism in Acute Myeloid Leukemia Patients
por: Fovez, Quentin, et al.
Publicado: (2021)

Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-Leukemic Reactivity in Patients with Chronic Myelogenous Leukemia
por: Catellani, Silvia, et al.
Publicado: (2011)

The role of mitochondrial proteases in leukemic cells and leukemic stem cells
por: Mirali, Sara, et al.
Publicado: (2020)

Elaboration, structural study and validation of a new NASICON-type structure, Na(0.72)(Cr(0.48),Al(1.52))(Mo(2.77),Al(0.23))O(12)
por: Sonni, Manel, et al.
Publicado: (2018)

RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage
por: Nugues, A-L, et al.
Publicado: (2014)

Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities
por: Marchand, Tony, et al.
Publicado: (2021)

Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity
por: Mopin, Alexia, et al.
Publicado: (2022)

The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010)

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics
por: Marchetti, Philippe, et al.
Publicado: (2015)

Primary imatinib failure rescued by dasatinib and maintained by reintroduction of imatinib
por: Kumar, Rajiv, et al.
Publicado: (2017)

Leukemic Ischemia: A Case of Myocardial Infarction Secondary to Leukemic Cardiac Involvement
por: Fursevich, Dzmitry, et al.
Publicado: (2017)

A New Strategy to Preserve and Assess Oxygen Consumption in Murine Tissues
por: Kluza, Jerome, et al.
Publicado: (2021)

Fluorouracil Selectively Enriches Stem-like Leukemic Cells in a Leukemic Cell Line
por: Zhang, Ling, et al.
Publicado: (2010)

Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors
por: Corazao-Rozas, Paola, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f200u2510gjfro4j72qnvj1gvo